Evidence map›Paper›PMID 34398323›Full record

ReviewAMB Express2021

The varying effects of antibiotics on gut microbiota.

Lulu Yang, Ousman Bajinka, Pa Omar Jarju, Yurong Tan, Aji Mary Taal, Guven Ozdemir

3 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in AMB Express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 71 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 4 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05840588 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Bifidobacterium Breve PRL2020 (an Amoxicillin-Clavulanate-Resistant Strain) on Gastrointestinal Symptoms and Gut Microbiota Composition in Children Treated With Amoxicillin or Amoxicillin/Clavulanate: Results of a Pediatric, Multicenter, Randomized, Controlled, Prospective Study

TypeinterventionalSponsorLiaquat University of Medical & Health SciencesRan2023 to 2025Enrolled121ConditionsBacterial InfectionsArmsAntibiotic Treatment, Probiotic Bifidobacterium breve PRL2020 (Brevicillin®) treatment
NCT06850714 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of the Use of Bifidobacterium Breve PRL2020 in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use: A Randomized Controlled Trial

TypeinterventionalSponsorLiaquat University of Medical & Health SciencesRan2025 to 2025Enrolled800ConditionsAntibiotic Side EffectArmsBifidobacterium breve PRL2020 (Brevicillin®), Amoxicillin or Amoxicillin/Clavulanic Acid
NCT07234448 nacompletednot on this mapstarted 2025, after this paper: background citation

Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use: a Multicentre, Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial

TypeinterventionalSponsorLiaquat University of Medical & Health SciencesRan2025 to 2026Enrolled1,100ConditionsAntibiotic-associated DiarrheaArmsBrevicillin® gocce (Bifidobacterium breve PRL2020), Placebo (matching oil drops)
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 4 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Frontiers in immunology · 2026
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Lulu YangDepartment of Medical Microbiology, Central South University, Changsha, Hunan, China.
Ousman BajinkaDepartment of Medical Microbiology, Central South University, Changsha, Hunan, China.
Pa Omar JarjuSchool of Medicine and Allied Health Sciences, University of The Gambia, Serrekunda, Gambia.
Yurong TanDepartment of Medical Microbiology, Central South University, Changsha, Hunan, China. yurongtan@csu.edu.cn.ORCID http://orcid.org/0000-0002-2871-4078
Aji Mary TaalDepartment of Microbiology, University of Nottingham, Nottingham, UK.
Guven OzdemirSection of Basic and Industrial Microbiology, Department of Biology, Faculty of Science, Ege University, Izmir, Turkey.
Central South University · CNEge University · TRUniversity of Nottingham · GBUniversity of the Gambia · GM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics are lifesaving therapeutic drugs that have been used by human for decades. They are used both in the fight against bacterial pathogens for both human and for animal feeding. However, of recent, their effects on the gut microbial compositions and diversities have attracted much attention. Existing literature have established the dysbiosis (reduced diversity) in the gut microbiota in association with antibiotic and antibiotic drug doses. In the light of spelling out the varying effects of antibiotic use on gut microbiota, this review aimed at given an account on the degree of gut microbial alteration caused by common antibiotics. While some common antibiotics are found to destroy the common phyla, other debilitating effects were observed. The effects can be attributed to the mode of mechanism, the class of antibiotic, the degree of resistance of the antibiotic used, the dosage used during the treatment, the route of administration, the pharmacokinetic and pharmacodynamics properties and the spectrum of the antibiotic agent. Health status, stress or the type of diet an individual feeds on could be a great proportion as confounding factors. While it is understood that only the bacterial communities are explored in the quest to establishing the role of gut in health, other gut microbial species are somehow contributing to the dysbiosis status of the gut microbiota. Until now, long term natural fluctuations like diseases outbreaks and mutations of the strain might as well rendered alteration to the gut independent of antibiotic treatments.

Indexed as

AntibioticsBroad spectrum antibioticsDysbiosisGut healthGut microbiotaNarrow spectrum

Identifiers

PMID34398323
PMCPMC8368853
OpenAlexW3194937147

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.